PT1545428E - Processo para diminuir o nível da agregação de uma proteína peguilada - Google Patents

Processo para diminuir o nível da agregação de uma proteína peguilada Download PDF

Info

Publication number
PT1545428E
PT1545428E PT03754774T PT03754774T PT1545428E PT 1545428 E PT1545428 E PT 1545428E PT 03754774 T PT03754774 T PT 03754774T PT 03754774 T PT03754774 T PT 03754774T PT 1545428 E PT1545428 E PT 1545428E
Authority
PT
Portugal
Prior art keywords
peg
pegylated
protein
isoforms
growth hormone
Prior art date
Application number
PT03754774T
Other languages
English (en)
Portuguese (pt)
Inventor
Anurag S Rathore
Denis M Boyle
John J Buckley
Gary V Johnson
David E Steinmeyer
Michele Toal
Serdar Aykent
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/646,798 external-priority patent/US20040048315A1/en
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of PT1545428E publication Critical patent/PT1545428E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/32—Extraction; Separation; Purification by precipitation as complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PT03754774T 2002-09-20 2003-09-22 Processo para diminuir o nível da agregação de uma proteína peguilada PT1545428E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41222702P 2002-09-20 2002-09-20
US10/646,798 US20040048315A1 (en) 2002-08-28 2003-08-25 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
US66288403A 2003-09-16 2003-09-16

Publications (1)

Publication Number Publication Date
PT1545428E true PT1545428E (pt) 2010-02-25

Family

ID=32034217

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03754774T PT1545428E (pt) 2002-09-20 2003-09-22 Processo para diminuir o nível da agregação de uma proteína peguilada

Country Status (17)

Country Link
EP (1) EP1545428B1 (cg-RX-API-DMAC7.html)
JP (1) JP4633463B2 (cg-RX-API-DMAC7.html)
KR (1) KR101120130B1 (cg-RX-API-DMAC7.html)
AT (1) ATE453662T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003272585B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0314120B8 (cg-RX-API-DMAC7.html)
CA (1) CA2498886C (cg-RX-API-DMAC7.html)
DE (1) DE60330787D1 (cg-RX-API-DMAC7.html)
DK (1) DK1545428T3 (cg-RX-API-DMAC7.html)
ES (1) ES2337041T3 (cg-RX-API-DMAC7.html)
HK (1) HK1079798B (cg-RX-API-DMAC7.html)
IL (1) IL167538A (cg-RX-API-DMAC7.html)
MX (1) MXPA05003121A (cg-RX-API-DMAC7.html)
PL (1) PL212726B1 (cg-RX-API-DMAC7.html)
PT (1) PT1545428E (cg-RX-API-DMAC7.html)
SI (1) SI1545428T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004026251A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06007848A (es) * 2004-02-09 2006-09-04 Pharmacia Corp Conjugados de antagonistas del receptor de hormona del crecimiento humana modificados quimicamente.
JP2008525032A (ja) * 2004-12-22 2008-07-17 アンブレツクス・インコーポレイテツド 組換えヒト成長ホルモンを発現及び精製するための方法
WO2011018515A1 (en) * 2009-08-14 2011-02-17 Novo Nordisk Health Care Ag Method of purifying pegylated proteins
US9562252B2 (en) * 2011-05-13 2017-02-07 Biogen Ma Inc. Methods of preventing and removing trisulfide bonds
KR20140062044A (ko) 2011-08-25 2014-05-22 에프. 호프만-라 로슈 아게 양이온 및 음이온 교환 크로마토그래피 방법
CN111801120A (zh) * 2017-12-29 2020-10-20 豪夫迈·罗氏有限公司 用于提供聚乙二醇化蛋白质组合物的方法
CN112107880B (zh) * 2020-09-16 2022-08-09 珠海中科先进技术研究院有限公司 一种低共熔混合物及利用其萃取鲟鱼鱼籽蛋白质的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US5153265A (en) 1988-01-20 1992-10-06 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5969109A (en) * 1990-02-28 1999-10-19 Bona; Constantin Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
DK44593D0 (da) * 1993-04-20 1993-04-20 Novo Nordisk As Fremgangsmaade til fremstilling af et polypeptid
ZA955789B (en) * 1994-07-15 1996-03-11 Novo Nordisk As A method of converting a hydrophobic derivative of a polypeptide into the native form
WO1996040731A1 (en) * 1995-06-07 1996-12-19 Mount Sinai School Of Medicine Of The City University Of New York Pegylated modified proteins
ATE455171T1 (de) * 1995-09-21 2010-01-15 Genentech Inc Varianten des menschlichen wachstumshormons
SE9802454D0 (sv) * 1998-07-08 1998-07-08 Pharmacia & Upjohn Ab Production of peptides
SE9904502D0 (sv) * 1999-12-09 1999-12-09 Pharmacia & Upjohn Ab Production of peptides

Also Published As

Publication number Publication date
BRPI0314120B1 (pt) 2020-12-29
MXPA05003121A (es) 2005-06-22
WO2004026251A3 (en) 2004-09-02
JP4633463B2 (ja) 2011-02-16
IL167538A (en) 2015-10-29
EP1545428A4 (en) 2006-03-01
KR101120130B1 (ko) 2012-04-18
ATE453662T1 (de) 2010-01-15
EP1545428A2 (en) 2005-06-29
PL375443A1 (en) 2005-11-28
CA2498886A1 (en) 2004-04-01
AU2003272585A1 (en) 2004-04-08
HK1079798A1 (zh) 2006-04-13
SI1545428T1 (sl) 2010-03-31
EP1545428B1 (en) 2009-12-30
JP2006516021A (ja) 2006-06-15
ES2337041T3 (es) 2010-04-20
WO2004026251A2 (en) 2004-04-01
HK1079798B (zh) 2010-11-19
AU2003272585B2 (en) 2009-12-10
BRPI0314120B8 (pt) 2021-05-25
DK1545428T3 (da) 2010-05-03
DE60330787D1 (de) 2010-02-11
KR20050046011A (ko) 2005-05-17
BR0314120A (pt) 2005-07-12
PL212726B1 (pl) 2012-11-30
CA2498886C (en) 2013-06-25

Similar Documents

Publication Publication Date Title
CN1703421B (zh) 降低peg化蛋白的聚集体水平的方法
ES2626248T3 (es) Proceso para la purificación de glucoproteínas
CN101087805B (zh) Fsh的纯化方法
BRPI1012647B1 (pt) Método para purificar um hormônio folículo-estimulante recombinante ou uma variante de hormônio folículo-estimulante recombinante
JP5199112B2 (ja) Fsh又はfsh変異体を精製するための方法
ES2307585T3 (es) Procedimiento para purificar hcg recombinante que tiene una bioactividad especifica.
JP7801104B2 (ja) ポリエチレングリコール(peg)-インターロイキン11(il-11)コンジュゲートを生成するための反応中間体、および、peg-il-11コンジュゲートを精製する方法
JP2004522445A (ja) 低減された免疫原性を有する修飾されたエリスロポエチン(epo)
NZ515381A (en) Purification of recombinant human growth hormone, antagonists and homologues using two-phase extraction methods wherein no chaotropic agent is used
EP0173384A2 (en) Polypeptide relating to alpha-hANP
IE57097B1 (en) Polypeptides
JP4633463B2 (ja) Peg化タンパク質の凝集レベルを低下させるための方法
CN1494551A (zh) 免疫原性减弱的经修饰粒细胞巨噬细胞集落刺激因子(gm-csf)
JP2022511951A (ja) Peg化された成長ホルモンアンタゴニスト
ES2309168T3 (es) Factor modificado estimulante de colonias de granulocitos (g-csf) con inmunogenicidad reducida.
MacWright et al. Isolation and characterization of pepsin-solubilized human basement membrane (type IV) collagen peptides
JP2004533812A (ja) 低減された免疫原性を有する修飾されたトロンボポエチン
ES2572629T3 (es) Método para purificar FSH o un mutante de FSH
JPH01500188A (ja) ヘパトーム由来成長因子
Hosang et al. cDNA cloning identified a calmodulin-binding protein in bovine seminal plasma as bovine C-type natriuretic peptide
CN103087182A (zh) 一种定点修饰n-末端的聚乙二醇化生长激素拮抗剂及其制备方法
Sherwood Isolation and characterization of porcine and rat relaxin
Bustamante Purification and characterization of a glycosylated 24 kDa human growth hormone molecular variant